$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
度伐利尤单抗(Imfinzi)的中文说明书
2025-10-19 11:44:20
Check Details
治疗鼻咽癌的低毒性选择:奈达铂化疗
2025-10-19 11:44:20
Check Details
FDA批准阿维鲁单抗(Avelumab)用于转移性默克尔细胞癌、晚期或转移性尿路上皮癌以及与阿西替尼联合用于晚期肾细胞癌的治疗
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)用法用量:推荐剂量,剂量调整、不良反应剂量调整
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)的不良反应和副作用
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)详细说明书
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼对胶质瘤亚型有良好疗效
2025-10-19 11:44:20
Check Details
靶向药物艾伏尼布治疗胶质瘤疗效强劲
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗BRAF V600E突变型胶质瘤具有持久的临床受益
2025-10-19 11:44:20
Check Details
berubicin获批加速通道指定!多形性胶质母细胞瘤迎来新疗法
2025-10-19 11:44:20
Check Details
FDA授予LP-184治疗多形性胶质母细胞瘤和恶性胶质瘤的孤儿药称号
2025-10-19 11:44:20
Check Details
1
2
...
19
20
21
22
23
24
25
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
2
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
3
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
4
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
5
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
6
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
7
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
8
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
9
Vemurafenib (Zelboraf) Complete Medication Guide
10
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
11
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
12
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options